PMID: 18486045DOI: 10.1016/s1472-9792(08)70011-8May 20, 2008Paper

Isoniazid

Tuberculosis

Abstract

No abstract listed.

References

Toxicity of antibacterial agents: mechanism of action on mammalian cells

Jan 1, 1979·Annual Review of Pharmacology and Toxicology·W E Sanders, C C Sanders

Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice.

Mar 1, 1992·Antimicrobial Agents and Chemotherapy·J GrossetB Ji

Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis

Mar 17, 1995·Science·A DessenJ C Sacchettini

In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages

Sep 1, 1996·Current Microbiology·N RastogiK S Goh

Isoniazid drug and food interactions

May 20, 1999·The American Journal of the Medical Sciences·T H SelfM S Bronze

Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates

Jun 16, 2001·Antimicrobial Agents and Chemotherapy·A S LeeS Y Wong

Crystal structure of MabA from Mycobacterium tuberculosis, a reductase involved in long-chain fatty acid biosynthesis

Jun 25, 2002·Journal of Molecular Biology·Martin Cohen-GonsaudAnnaïk Quemard

Oxidative stress increases susceptibility of Mycobacterium tuberculosis to isoniazid.

Aug 17, 2002·Antimicrobial Agents and Chemotherapy·Vanja M BulatovicFrank Rusnak

Chemotherapeutic activity against murine tuberculosis of once weekly administered drugs (isoniazid and rifampicin) encapsulated in liposomes

Oct 19, 2002·International Journal of Antimicrobial Agents·Sumeet LabanaG K Khuller

Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis

Sep 10, 2005·International Journal of Antimicrobial Agents·Y BhusalN Yamane

❮ Previous
Next ❯

Citations

Rapid measurement of antituberculosis drug activity in vitro and in macrophages using bioluminescence.

Nov 22, 2011·The Journal of Antimicrobial Chemotherapy·Nuria AndreuBrian D Robertson

New 1,4-di-N-oxide-quinoxaline-2-ylmethylene isonicotinic acid hydrazide derivatives as anti-Mycobacterium tuberculosis agents

May 17, 2011·Bioorganic & Medicinal Chemistry Letters·Enrique TorresSilvia Pérez-Silanes

Peptide Targeting of an Antibiotic Prodrug toward Phagosome-Entrapped Mycobacteria

Sep 14, 2016·ACS Infectious Diseases·Mark P PereiraShana O Kelley

Antioxidant, Hepatoprotective Potential and Chemical Profiling of Propolis Ethanolic Extract from Kashmir Himalaya Region Using UHPLC-DAD-QToF-MS

Nov 6, 2015·BioMed Research International·Adil F WaliMubashir Hussain Masoodi

Extra-Pulmonary Tuberculosis and Its Surgical Treatment

Apr 9, 2016·Surgical Infections·Donald E Fry

Turning the respiratory flexibility of Mycobacterium tuberculosis against itself

Aug 11, 2016·Nature Communications·Dirk A LamprechtAdrie J C Steyn

Nanostructured drug delivery for better management of tuberculosis

Apr 16, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Indu Pal Kaur, Harinder Singh

Natural cinnamic acids, synthetic derivatives and hybrids with antimicrobial activity.

Nov 28, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Juan David Guzman

Elucidating drug-enzyme interactions and their structural basis for improving the affinity and potency of isoniazid and its derivatives based on computer modeling approaches.

Apr 30, 2010·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Auradee PunkvangPornpan Pungpo

Caution when treating tuberculosis in malnourished children

Aug 23, 2018·Archives of Disease in Childhood·Kazeem Adeola Oshikoya, Idowu Odunayo Senbanjo

Intensified antibiotic treatment of tuberculosis meningitis

Nov 27, 2018·Expert Review of Clinical Pharmacology·Fiona V CresswellReinout Van Crevel

Recent advances toward the inhibition of mAG and LAM synthesis in Mycobacterium tuberculosis

Jan 26, 2010·Medicinal Research Reviews·Francis E UmesiriSteven J Sucheck

Prevention and treatment of tuberculosis in solid organ transplant recipients

Dec 13, 2019·Expert Review of Anti-infective Therapy·Cybele L Abad, Raymund R Razonable

Calix[4]arene based 1,3,4-oxadiazole and thiadiazole derivatives: design, synthesis, and biological evaluation

Jan 17, 2012·Organic & Biomolecular Chemistry·Manishkumar B PatelShobhana K Menon

Hepatotoxicity mechanisms of isoniazid: A mini-review

Jun 23, 2015·Journal of Applied Toxicology : JAT·Hozeifa M HassanJiang Zhenzhou

Evaluation of Proinflammatory Cytokines and Adverse Events in Healthy Volunteers upon Inhalation of Antituberculosis Drugs

Nov 3, 2016·Biological & Pharmaceutical Bulletin·Teerapol SrichanaAlwar Ramanujam Padmavathi

Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy

Jul 8, 2017·Microbiome·Sivaranjani NamasivayamAlan Sher

Multi-Methodological Quantitative Taste Assessment of Anti-Tuberculosis Drugs to Support the Development of Palatable Paediatric Dosage Forms

Apr 23, 2020·Pharmaceutics·Alison V KeatingCatherine Tuleu

Synthesis and Tuberculostatic Activity Evaluation of Novel Benzazoles with Alkyl, Cycloalkyl or Pyridine Moiety

Apr 25, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Malwina KrauseKatarzyna Gobis

The Microbiome and Tuberculosis: Early Evidence for Cross Talk

Sep 20, 2018·MBio·Sivaranjani NamasivayamMatthew F Wipperman

PharmGKB summary: isoniazid pathway, pharmacokinetics

May 28, 2016·Pharmacogenetics and Genomics·Daniel J KleinTeri E Klein

Is IQG-607 a Potential Metallodrug or Metallopro-Drug With a Defined Molecular Target in Mycobacterium tuberculosis ?

May 17, 2018·Frontiers in Microbiology·Bruno L AbbadiLuiz A Basso

NAT2 polymorphisms associated with the development of hepatotoxicity after first-line tuberculosis treatment in Mexican patients: From genotype to molecular structure characterization.

May 2, 2021·Clinica Chimica Acta; International Journal of Clinical Chemistry·Aldo Herrera-RodulfoBeatriz Silva-Ramirez

Host Bioenergetic Parameters Reveal Cytotoxicity of Antituberculosis Drugs Undetected Using Conventional Viability Assays.

Aug 3, 2021·Antimicrobial Agents and Chemotherapy·Bridgette M CummingAdrie J C Steyn

Drug targets exploited in Mycobacterium tuberculosis: Pitfalls and promises on the horizon

Jun 6, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Zubair Shanib BhatZahoor Ahmad

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Related Papers

ContactHelpTerms Privacy Cookies
© 2022 Meta ULC. All rights reserved